马杏, 刘畅. FIGO 2018 IIIC期宫颈癌的预后及治疗策略[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2024-0097
引用本文: 马杏, 刘畅. FIGO 2018 IIIC期宫颈癌的预后及治疗策略[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2024-0097
MA Xing, LIU Chang. Prognosis and Treatment Strategies Of FIGO 2018 Stage IIIC Cervical Cancer[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0097
Citation: MA Xing, LIU Chang. Prognosis and Treatment Strategies Of FIGO 2018 Stage IIIC Cervical Cancer[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0097

FIGO 2018 IIIC期宫颈癌的预后及治疗策略

Prognosis and Treatment Strategies Of FIGO 2018 Stage IIIC Cervical Cancer

  • 摘要: 肿瘤分期和淋巴结受累是局部晚期宫颈癌最重要的预后因素。对于宫颈癌,妇科肿瘤医师普遍应用国际妇产科联盟(InternationalFederation of Gynecology and Obstetrics,FIGO)标准。然而目前FIGO 2018分期标准中,IIIC期仅基于转移淋巴结的解剖位置,并未考虑局部肿瘤因素及其他淋巴状态参数,一定程度上限制了其预后意义。本综述旨在总结IIIC期宫颈癌局部肿瘤因素及不同淋巴状态参数对预后的影响以及治疗的选择。

     

    Abstract: Tumor stage and lymph node involvement are the most important prognostic factors for patients with locally advanced cervical cancer. For cervical cancer, gynecologic oncologists generally apply the criteria of the International Federation of Gynecology and Obstetrics. However, stage IIIC is only based on the anatomical location of metastatic lymph nodes, without considering local tumor factors and other lymphatic status parameters in the current FIGO 2018 staging system, which limits its prognostic significance to a certain extent. The aim of this review is to summarize the influence of local tumor factors and different lymphatic status parameters on prognosis and treatment options for stage IIIC cervical cancer.

     

/

返回文章
返回